P. Kvacskay

Targeting of Janus Kinases Limits Pro-Inflammatory but Also Immunosuppressive Circuits in the Crosstalk between Synovial Fibroblasts and Lymphocytes

W. Merkt, Hanns-Martin Lorenz, T. Tretter, 2021, Biomedicines.

Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series

W. Merkt, Hanns-Martin Lorenz, N. Blank, 2022, Annals of the Rheumatic Diseases.

Increase of aerobic glycolysis mediated by activated T helper cells drives synovial fibroblasts towards an inflammatory phenotype: new targets for therapy?

W. Merkt, H. Lorenz, K. Klika, 2021, Arthritis Research & Therapy.